Human teratogens and evidence-based teratogen risk counseling: The Motherisk approach

Alejandro A. Nava-Ocampo, Gideon Koren

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

There are only a limited number of drugs proven to be human teratogens including thalidomide, isotretinoin, coumarin derivates, valproic acid, and folate antagonists. In some cases, the combination of 2 drugs may increase the teratogenic risk. The risk of birth defects may also vary with the time at which the drug is administered during pregnancy and the dose. There are some examples of drugs in which the dose has proven to be a major determinant of their teratogenicity in humans. There is more safety information for older than for newer drugs. Proactive teratogen risk counseling should include a critical appraisal of all available data including the consequences of the untreated maternal condition.

Original languageEnglish
Pages (from-to)123-131
Number of pages9
JournalClinical Obstetrics and Gynecology
Volume50
Issue number1
DOIs
StatePublished - Mar 2007
Externally publishedYes

Keywords

  • Maternal fetal relations
  • Maternal health services
  • Prenatal care
  • Risk-benefit assessment

Fingerprint

Dive into the research topics of 'Human teratogens and evidence-based teratogen risk counseling: The Motherisk approach'. Together they form a unique fingerprint.

Cite this